Sagimet Biosciences (SGMT) Stock Price
$2.21 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
6 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Sagimet Biosciences, AI stock picks, stock alerts and much more.
SGMT AI Stock Analysis
AI stock analysis for SGMT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sagimet Biosciences (SGMT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Sagimet Biosciences (SGMT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sagimet Biosciences (SGMT), currently trading at $2.21, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SGMT
-
Sagimet Biosciences Inc.
-
Symbol
SGMT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
67.8M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
SGMT Alternative Data
Web Traffic
Sagimet Biosciences receives an estimated 3585 monthly visitors to sagimet.com.
-
Web Traffic
3585
-
Change from Previous Month
4.4%
-
3 Month Change
45.8%
-
YoY Change
45.8%
News Mentions
Sagimet Biosciences was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Reddit Mentions
Sagimet Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Followers
3,580 are following Sagimet Biosciences on LinkedIn, up by 1.3% over the last month.
-
LinkedIn Followers
3580
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
3.3%
Job Postings
Sagimet Biosciences currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Sagimet Biosciences has 210 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.9% over the last month.
-
Twitter Followers
210
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
9.4%
-
YoY Change
9.4%
LinkedIn Employees
According to LinkedIn, Sagimet Biosciences has 19 employees.
-
LinkedIn Employees
19
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
9.5%
-
YoY Change
9.5%
SGMT Financials
SGMT Key Metrics
-
Total Revenue
$0
-
Net Income
-$16.2M
-
Earnings per Share
-$0.5
-
Free cash flow
-$11M
-
EBITDA
-$18.2M
-
EBITDA Ratio
0
-
Total Assets
$160.3M
SGMT 2-year Revenue & Income
SGMT 2-year Free Cash Flow
SGMT Technicals
SGMT SMA
SGMT RSI
FAQ
What's the current price of Sagimet Biosciences (SGMT) Stock?
The price of an Sagimet Biosciences (SGMT) share is $2.21.
What's the market cap of Sagimet Biosciences?
The current market cap of Sagimet Biosciences is 67.8M.
Should I buy or sell SGMT?
Sagimet Biosciences shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Sagimet Biosciences is better viewed as a hold or accumulate position while waiting for further developments.
Is Sagimet Biosciences a good investment?
The current analysis of Sagimet Biosciences' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Sagimet Biosciences' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Sagimet Biosciences (SGMT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Sagimet Biosciences stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Sagimet Biosciences (SGMT) that investors often compare it to?
Sagimet Biosciences (SGMT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Sagimet Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sagimet Biosciences' stock price to be around $2.3 in 2026. Starting from the current price of $2.21, this represents a 4.2% change in price, indicating a neutral outlook for the stock.
How to buy Sagimet Biosciences (SGMT) Stock?
Sagimet Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sagimet Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.